The in vitro release characteristics investigated fitted to first order pharmacokinetic model.
体外释药速率符合一级动力学模型。
Objective:To establish the pharmacokinetic model for a target therapeutic system of sustained-release implants.
目的：创建缓释植入剂局部给药治疗系统的药动学模型。
Introduction to Physiologically Based Pharmacokinetic Model Construction: an Example of 1, 1, 1-trichloroethane.
以1,1,1 -三氯乙烷为例介绍生理药代动力学模型的建立。
Analysis of the data was executed by compartmental model and statistical moment calculation from which pharmacokinetic parameters were obtained.
药物浓度对时间数据作房室模型和统计矩解析，并求出相应的药动学参数。
The pharmacokinetic parameters were calculated according to non - compartment model.
用非房室模型参数估算法计算药动学参数。
Pharmacokinetic parameters were assessed with noncompartment model and model-dependent method.
由非房室和房室模型评价药物动力学参数。
The concentration of methyclothiazide in blood plasma was measured by an validated LC-MS/MS method and were assessed with non-compartment model to obtain the pharmacokinetic parameters.
方法采用LC-MS/MS法测定血浆中甲氯噻嗪的浓度并用非房室模型计算药动学参数。
A pharmacokinetic and pharmacodynamic model is employed to determine optimum drug formulations and optimum parameters for administration.
本发明应用了药动学模型和药效学模型来确定最适的药物制剂和最适的施用参数。
RESULTS:The pharmacokinetic parameters could be described as one-compartment model.
结果：符合一室动力学模型。
The fundamental pharmacokinetic principles are based upon the most elementary kinetic model.
学的基本原理是以最基本的动力学模型为依据。
The fundamental pharmacokinetic principles are based upon the most elementary kinetic model.
学的基本原理是以最基本的动力学模型为依据。
应用推荐